IRD: Opus Genetics, Inc. Stock

by  •  • Comments Off on IRD: Opus Genetics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 43.08
Enterprise Value ($M) 31.60
Book Value ($M) 25.57
Book Value / Share 0.56
Price / Book 1.69
NCAV ($M) 25.32
NCAV / Share 0.56
Price / NCAV 1.70

Profitability (mra)
Return on Invested Capital (ROIC) -2.25
Return on Assets (ROA) -1.11
Return on Equity (ROE) -1.25

Liquidity (mrq)
Quick Ratio 3.24
Current Ratio 3.24

Balance Sheet (mrq) ($M)
Current Assets 36.61
Assets 36.86
Liabilities 11.29
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 10.99
Operating Income -34.07
Net Income -57.53
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -25.58
Cash from Investing 1.21
Cash from Financing 4.19

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
4 days ago 13D/A Foundation Fighting Blindness Retinal Degeneration Fund 15.90 270.10
03-31 13G Perceptive Advisors Llc 9.99

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-31 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2024 ☐ TRANSITION REPORT

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-09 8,167 55,341 14.76
2025-05-08 61,181 298,423 20.50
2025-05-07 116,341 574,715 20.24
2025-05-06 28,367 97,648 29.05
2025-05-05 7,176 52,136 13.76

(click for more detail)

Similar Companies
INO – Inovio Pharmaceuticals, Inc. INTS – Intensity Therapeutics, Inc.
IPA – ImmunoPrecise Antibodies Ltd. ITRM – Iterum Therapeutics plc
JAGX – Jaguar Health, Inc.


Financial data and stock pages provided by
Fintel.io